Intensity-Modulated Radiotherapy in Patients with Cervical Cancer. An intra-individual Comparison of Prone and Supine Positioning

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Stromberger, Carmen ^a   Kom, Yves ^a   Kawgan Kagan, Michael ^a   Mensing, Tristan ^a   Jahn, Ulrich ^a   Schneider, Achim ^a   Budach, Volker ^a   Köhler, Christhardt ^a   Marnitz, Simone ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CAPACITY; BODY POSTURE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; RADIATION DOSE; RECTUM; SUPINE POSITION; TREATMENT OUTCOME; UTERINE CERVIX CANCER; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; METHODOLOGY; PATHOLOGY; RADIOMETRY; UTERINE CERVIX TUMOR;

FEMALE; HUMANS; NEOPLASM STAGING; PRONE POSITION; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; SUPINE POSITION; UTERINE CERVICAL NEOPLASMS;

EID: 77954037609     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-63     Document Type: Article

References (48)

1. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001, 358:781-786. 10.1016/S0140-6736(01)05965-7, 11564482.
2. Hänsgen G, Kuhnt T, Pigorsch S, Strauss H, Dunst J. Adjuvant simultaneous radiochemotherapy after operated uterine cervix carcinoma in high risk situation. Results of a pilot study. Strahlenther Onkol 2002, 178:71-77. 10.1007/s00066-002-0914-y, 11942040.
3. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. NEJM 1999, 340:1137-1143. 10.1056/NEJM199904153401501, 10202164.
4. Nagy V, Coza O, Ordeanu C, Trǎilǎ A, Rancea A, Todor N, Ghilezan N. Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial. Strahlenther Onkol 2009, 185:177-183. 10.1007/s00066-009-1893-z, 19330295.
5. Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W, Alberts DS. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000, 18:1606-1613.
6. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144-1153. 10.1056/NEJM199904153401502, 10202165.
7. Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol 2005, 96:490-495. 10.1016/j.ygyno.2004.10.038, 15661240.
8. Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 2002, 178:378-385. 10.1007/s00066-002-0956-1, 12163992.
9. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, Clarke-Pearson DL, Liao SY. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecology Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999, 17:1339-1348.
10. Andreyev HJ. Gastrointestinal problems after pelvic radiotherapy: the past, the resent and the future. Clin Oncol (R Coll Radiol) 2007, 19:790-799.
11. Kirwan JM, Symonds P, Green JA, Tierney J, Collingwood M, Williams CJ. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 2003, 68:217-226. 10.1016/S0167-8140(03)00197-X, 13129628.
12. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989, 32:292-296. 10.1016/0090-8258(89)90627-6, 2920950.
13. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997, 350:535-540. 10.1016/S0140-6736(97)02250-2, 9284774.
14. Gallagher MJ, Brereton HD, Rostock RA, Zero JM, Zekoski DA, Poyss LF, Richter MP, Kligerman MM. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 1986, 12:1565-1573.
15. Huang EY, Sung CC, Ko SF, Wang CJ, Yang KD. The different volume effects of small-bowel toxicity during pelvic irradiation between gynecologic patients with and without abdominal surgery: a prospective study with computed tomography-based dosimetry. Int J Radiat Oncol Biol Phys 2007, 69:732-739.
16. Letschert JG, Lebesque JV, de Boer RW, Hart AA, Bartelink H. Dose-volume correlation in radiation-related late small-bowel complications: a clinical study. Radiother Oncol 1990, 18:307-320. 10.1016/0167-8140(90)90111-9, 2244018.
17. Letschert JG, Lebesque JV, Aleman BM, Bosset JF, Horiot JC, Bartelink H, Cionini L, Hamers JP, Leer JW, van Glabbeke M. The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol 1994, 32:116-123. 10.1016/0167-8140(94)90097-3, 7972904.
18. Beriwal S, Jain SK, Heron DE, de Andrade RS, Lin CJ, Kim H. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer. Int J Radiat Oncol Biol Phys 2007, 67:485-489.
19. Das IJ, Lanciano RM, Movsas B, Kagawa K, Barnes SJ. Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. Int J Radiat Oncol Biol Phys 1997, 39:67-76.
20. Ghosh K, Padilla LA, Murray KP, Downs LS, Carson LF, Dusenbery KE. Using a belly board device to reduce the small bowel volume within pelvic radiation fields in women with postoperatively treated cervical carcinoma. Gynecol Oncol 2001, 83:271-275. 10.1006/gyno.2001.6295, 11606083.
21. Martin J, Fitzpatrick K, Horan G, McCloy R, Buckney S, O'Neill L, Faul C. Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study. Radiother Oncol 2005, 74:267-274. 10.1016/j.radonc.2004.11.010, 15763307.
22. Olofsen-van Acht M, van den Berg H, Quint S, de Boer H, Seven M, van Sömsen de Koste J, Creutzberg C, Visser A. Reduction of irradiated small bowel volume and accurate patient positioning by use of a bellyboard device in pelvic radiotherapy of gynecological cancer patients. Radiother Oncol 2001, 59:87-93. 10.1016/S0167-8140(00)00279-6, 11295211.
23. Pinkawa M, Gagel B, Demirel C, Schmachtenberg A, Asadpour B, Eble MJ. Dose-volume histogram evaluation of prone and supine patient position in external beam radiotherapy for cervical and endometrial cancer. Radiother Oncol 2003, 69:99-105. 10.1016/S0167-8140(03)00244-5, 14597362.
24. Siddiqui F, Shi C, Papanikolaou N, Fuss M. Image-guidance protocol comparison: supine and prone set-up accuracy for pelvic radiation therapy. Acta Oncol 2008, 47:1344-1350. 10.1080/02841860802304564, 18663650.
25. Georg P, Georg D, Hillbrand M, Kirisits C, Pötter R. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol 2006, 80:19-26. 10.1016/j.radonc.2006.04.014, 16766068.
26. Heron DE, Gerszten K, Selvaraj RN, King GC, Sonnik D, Gallion H, Comerci J, Edwards RP, Wu A, Andrade RS, Kalnicki S. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled. Gynecol Oncol 2003, 91:39-45. 10.1016/S0090-8258(03)00461-X, 14529660.
27. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002, 52:1330-1337. 10.1016/S0360-3016(01)02785-7, 11955746.
28. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001, 51:261-266.
29. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000, 48:1613-1621.
30. Ahmed RS, Kim RY, Duan J, Meleth S, De Los Santos JF, Fiveash JB. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys 2004, 60:505-512.
31. D'Souza WD, Ahamad AA, Iyer RB, Salehpour MR, Jhingran A, Eifel PJ. Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma. Int J Radiat Oncol Biol Phys 2005, 61:1062-1070.
32. Vandecasteele K, De Neve W, De Gersem W, Delrue L, Paelinck L, Makar A, Fonteyne V, De Wagter C, Villeirs G, De Meerleer G. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation. Strahlenther Onkol 2009, 185:799-807. 10.1007/s00066-009-1986-8, 20013089.
33. Beriwal S, Gan GN, Heron DE, Selvaraj RN, Kim H, Lalonde R, Kelley JL, Edwards RP. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2007, 68:166-171.
34. Chen MF, Tseng CJ, Tseng CC, Kuo YC, Yu CY, Chen WC. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1438-1444.
35. Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Cancer J 2008, 14:200-206. 10.1097/PPO.0b013e318173a04b, 18536561.
36. Marnitz S, Köhler C, Roth C, Füller J, Bischoff A, Wendt T, Schneider A, Budach V. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging. Strahlenther Onkol 2007, 183:473-478. 10.1007/s00066-007-1675-4, 17762920.
37. International Commision on Radiation Units and Measurements Prescribing, recording and reporting photon beam therapy. ICRU Report 50. Bethesda 1993, International Commision on Radiation Units and Measurements.
38. International Commission on Radiation Units & Measurements Supplement to ICRU Report 50, ICRU Report 62. Bethesda 1999, International Commission on Radiation Units & Measurements.
39. Radiation Therapy Oncology Group. , http://www.rtog.org/
40. Marnitz S, Köhler C, Schneider A, Seiler F, Hinkelbein W. Interindividual variability of lymph drainages in patients with cervical cancer. Implication on irradiation planning. Strahlenther Onkol 2006, 182:80-85. 10.1007/s00066-006-1470-7, 16447014.
41. van't Riet A, Mak AC, Moerland MA, Elders LH, van der Zee W. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 1997, 37:731-736.
42. Marnitz S, Köhler C, Füller J, Hinkelbein W, Schneider A. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlenther Onkol 2006, 182:45-51. 10.1007/s00066-006-1455-6, 16404520.
43. Füller J, Guderian D, Köhler C, Schneider A, Wendt TG. Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol 2008, 184:206-211. 10.1007/s00066-008-1728-3, 18398585.
44. Bouchard M, Nadeau S, Gingras L, Raymond PE, Beaulieu F, Beaulieu L, Fortin A, Germain I. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 71:1343-1350.
45. Gerszten K, Colonello K, Heron DE, Lalonde RJ, Fitian ID, Comerci JT, Selvaraj RN, Varlotto JM. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 2006, 102:182-188. 10.1016/j.ygyno.2005.12.044, 16516281.
46. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003, 56:1354-1360. 10.1016/S0360-3016(03)00325-0, 12873680.
47. Salama JK, Mundt AJ, Roeske J, Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 2006, 65:1170-1176.
48. Adli M, Mayr NA, Kaiser HS, Skwarchuk MW, Meeks SL, Mardirossian G, Paulino AC, Montebello JF, Gaston RC, Sorosky JI, Buatti JM. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?. Int J Radiat Oncol Biol Phys 2003, 57:230-238.